Close menu

September 14th, 2022 | 11:55 CEST

First Hydrogen, Nel, Thyssenkrupp - Watch out: Stock gains with green hydrogen!

  • greenhydrogen
  • Hydrogen
  • Investments
Photo credits:

In view of exploding gas prices and the great dependence on Russia's energy supplies, efforts to expand the supply of renewable energies are a top priority worldwide. Green hydrogen is seen as a clean energy source with a bright future. Massive subsidies around the globe could soon herald a boom in this sector.

time to read: 3 minutes | Author: Carsten Mainitz
ISIN: First Hydrogen Corp. | CA32057N1042 , NEL ASA NK-_20 | NO0010081235 , THYSSENKRUPP AG O.N. | DE0007500001

Table of contents:

    First Hydrogen - Pole position

    Hydrogen is produced when an electric current is passed through water, separating hydrogen from oxygen. If the electricity used comes from renewable energy sources, it is referred to as green hydrogen. Given the positive general conditions, First Hydrogen recently announced its intention to exploit the potential in the US market.

    To this end, the Canadians have founded the companies First Hydrogen Energy Inc. and First Hydrogen Automotive Inc. in the United States. The recent passage of the Inflation Reduction Act authorized USD 369 billion in investments for energy and climate change.

    No less significant than the development in the US is the declaration of intent by Germany and Canada to invest in hydrogen and establish a transatlantic supply corridor between the two countries. That puts First Hydrogen in pole position to benefit from this development.

    In the future, the Canadians want to cover the complete hydrogen value chain. Together with globally established partners such as Ballard Power and AVL Powertrain UK, as well as a "best-of strategy," the Company is working on developing and producing zero-emission, hydrogen-powered commercial vehicles.

    In addition, the Company is working to build a "Hydrogen-as-a-Service Model," which is a zero-emission, global ecosystem solution. Company representative Robert Campbell will present First Hydrogen live via Zoom at the 4th IIF - International Investment Forum on September 27, 2022. Attendance is free by registering via the website:

    Nel - Top but expensive

    The hydrogen specialist Nel ASA is one of the leading companies in solutions for producing, storing and distributing hydrogen from renewable energies. The Norwegians cover the entire value chain, i.e. from hydrogen production to the construction of hydrogen filling stations. From the highs in January 2021 in the range of NOK 35, the share price is now only around NOK 14, which still values the Company at the equivalent of around EUR 2.2 billion.

    The latest quarterly figures did not trigger any euphoria among market participants. Many analysts reduced their price targets for the shares. Credit Suisse formulated a target of NOK 10, while analysts at Bank of America consider NOK 11 an appropriate valuation level. The general tone is similar: although the future prospects of the industries look good, the analysts are skeptical that high volume growth will also be reflected on the profit side as strongly as the market forecasts and the Company valuation suggest.

    Recently, the Norwegians were able to land another forward-looking order. For the American ethanol producer LanzaJet, Nel will produce a container electrolyzer for the production of green aviation fuel. While this order, worth around USD 3 million, is a success story, investors should not forget that the Company is valued at 15 times 2023 sales and will be loss-making for many years to come.

    Thyssenkrupp - Equity story will change

    Sharply rising energy prices and the weakening economy have weighed on the share price in recent months. However, many analysts believe the shares are undervalued at their current level. With a target price of EUR 13.80, the experts at Jefferies believe that the stock can more than double in value within the next 12 months.

    The share price could soon gain momentum because, according to media reports, the Group is working on an IPO of its hydrogen subsidiary Nucera. An IPO is the preferred option for the Germans to exploit the potential of the business with facilities for the production of green hydrogen.

    The Company recently announced plans to build a hydrogen-based blast furnace in Duisburg, Germany, subject to government funding. The investments total more than EUR 2 billion. Group CEO Martina Merz thus emphasized "making a decisive and, above all, rapid contribution to the green transformation in steel as well."

    The energy transition is opening up huge potential. Green hydrogen could soon experience a special boom due to subsidy measures. According to analysts, Nel is overvalued. Stock market plans for the hydrogen subsidiary could revive Thyssenkrupp's stock. The favorite in the sector is clearly First Hydrogen.

    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.

    Der Autor

    Carsten Mainitz

    The native Rhineland-Palatinate has been a passionate market participant for more than 25 years. After studying business administration in Mannheim, he worked as a journalist, in equity sales and many years in equity research.

    About the author

    Related comments:

    Commented by Stefan Feulner on October 4th, 2022 | 11:59 CEST

    RWE, Pathfinder Ventures, United Internet - Panic as an opportunity

    • Camping
    • Investments

    Last week, the crash prophets crawled out of their caves and outdid themselves with forecasts reaching the Corona lows at around 8,000 points in the leading German DAX index. Without a doubt, the general conditions for a sustained stock rally are moderate with the escalation of the Ukraine situation and concerns about further interest rate hikes. Nevertheless, there are attractive entry opportunities at the current level, which could pay off in cash in the long term.


    Commented by Juliane Zielonka on September 30th, 2022 | 10:59 CEST

    Biogen, XPhyto, BioNTech: Alzheimer's disease, depression, cancer - Pharma for life

    • Biotechnology
    • Pharma
    • Investments
    • Technology

    About 350 million people worldwide are affected by depression, a disorder of the brain. Each person also has a 16 to 20% chance of becoming depressed. Reason enough for the Canadian Company XPhyto Therapeutics to research a drug that is not addictive and can defeat the mental health-related medical condition. This week, Biogen, among others, achieved a breakthrough with an active substance against Alzheimer's disease. And if you follow the Bundesliga closely, you may be aware of the cases of testicular cancer among the players. Now BioNTech senses a new opportunity...


    Commented by Fabian Lorenz on September 29th, 2022 | 13:17 CEST

    Up to 200% share price potential: Kion, BioNTech, Aspermont in analyst check

    • Technology
    • Biotechnology
    • Investments

    The profit warning was a shock for Kion shareholders. Accordingly, the share price halved to EUR 20 in September alone. Now analysts are also slashing their estimates. The price targets for the forklift manufacturer are falling accordingly. Berenberg surprises with a high price target for the BioNTech share. At the same time, the analysts emphasize their hope for a continued generous dividend. Shareholders could thus be kept in good spirits until the next blockbuster. The roadshow of Aspermont in Germany has probably also created a good mood. At least the share price has jumped. The current consolidation could be an entry opportunity. Analysts see a price potential of over 200%.